Rising Demand for Regenerative Therapies and Personalized Medicine Fuels 10% Annual Growth

DUBLIN, April 5, 2023 /PRNewswire/ — The “Global Filtration Market (Focus on Biologics Manufacturing) – Distribution by Type of Filtration System, Type of Filter (based on use), Type of Assembly, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” report has been added to ResearchAndMarkets.com’s offering.

The report features an extensive study of the current market landscape and future opportunity for the players offering filters for biopharmaceutical use. The report answers many key questions related to this domain.

A key advancement in this industry has been the introduction of novel filtration systems, such as depth filtration systems, tangential flow filtration systems, virus filtration systems and chromatography filtration systems. These systems can be applied to a wide variety of application areas due to their flexible nature. In fact, several large pharma companies have already made investments to improve their conventional filtration technologies.

The primary goal behind introducing these filters is to achieve the highest possible purity and yield of the desired biological product, along with maintaining its safety and efficacy for use in human or animal health. Given the ongoing advancements in this domain, several companies have developed and launched their proprietary biopharmaceutical filtration systems for more efficient purification of biologics.

Benefits and Growing Demand for Biopharmaceutical Filtration Systems

Biopharmaceutical filtration systems are used to separate and purify biological products, such as proteins, antibodies and vaccines. These filtration systems offer several benefits over conventional systems, such as higher efficiency, enhanced product purity and higher throughput. Driven by these benefits, the demand for efficient biopharmaceutical filtration systems is anticipated to increase, resulting in lucrative opportunities for developers.

Current Market Landscape of Biopharmaceutical Filter Developers

The market landscape of biopharmaceutical filter developers features a mix of over 80 large, mid-sized and small companies, which have the required expertise to offer various biopharmaceutical filtration systems, across different scales of operation. It is worth mentioning that more than 80% of the companies have the ability to develop membrane filters. Further, the ongoing activity in this domain indicates that biopharmaceutical filtration system developers are continuously upgrading their capabilities and infrastructure to accommodate the current and anticipated future demand.

Key Drivers behind the Biopharmaceutical Filtration Market

The biopharmaceutical industry has rapidly expanded over the years, primarily driven by increasing prevalence of chronic diseases and rising demand for regenerative therapies and personalized medicines. This has, in turn, led to a subsequent escalation in demand for filtration systems for biologics. Further, the stringent government regulations and guidelines, such as Good Manufacturing Practices (GMP) and United States Pharmacopeia (USP) standards, established to ensure product safety and quality, has created a need for advanced filtration technologies. It is also worth highlighting that, adoption of single-use technologies, and development of new and advanced filtration systems, such as tangential flow filtration, chromatography filtration and virus filtration, are likely to create new opportunities in the market.

Market Size of the Biopharmaceutical Filtration Market

Driven by the rapid growth of the biopharmaceutical industry and increasing research and development activities, the future opportunities and growth associated with the filtration market for biologics is anticipated to witness a noteworthy growth in the foreseen future. Specifically, in terms of type of filter, the market is anticipated to be driven by membrane filters. Further, more than 60% of the market is anticipated to be represented by players based in North America and Europe, in the foreseen future.

Key Players in the Biopharmaceutical Filtration Market

Examples of key players engaged in this domain (which have also been captured in this report) include Asahi Kasei, Cobetter Filtration, Corning, Merck, Pall, Parker Hannifin, Sartorius and Thermo Fisher Scientific.

Scope of the Report

The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments.

The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes:

• A general overview of filtration systems, highlighting details on different types of filtration systems and steps involved in sterile filtration for bioprocessing. It also presents information on the factors affecting sterile filtration, advantages of biopharmaceutical filtration systems, challenges associated with biopharmaceutical filtration systems and applications of biopharmaceutical filtration. Additionally, it presents an overview of the ongoing trends and future perspectives of the biopharmaceutical filtration industry.
• A detailed assessment of the overall market landscape of companies offering biopharmaceutical filtration systems, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of filter system / element (depth filters, tangential flow filters, virus filters and other membrane filters) and application area(s) (viral clearance, cell culture clarification, cell separation / product purification, sterilization and others). In addition, it includes information on type of filter (based on use) (disposable or single-use and reusable or multi-use), type of filter module (encapsulated), type of media material (natural components, synthetic, polypropylene or glass microfiber), type of assembly (pod, capsule, cassette, hollow fibre, and others), novel filtration systems offered (chromatography filtration and tangential flow depth filtration) and type of technique(s) used (ultrafiltration, microfiltration and nanofiltration).
• A detailed competitiveness analysis of biopharmaceutical filtration system developers based in North America, Europe and Asia-Pacific, based on supplier strength (in terms of years of experience, company size and number of filter system / element offered), product strength (considering features of depth filters, tangential flow filters, virus filters, other membrane filters, novel filtration systems, type of technique(s) used) and application areas (viral clearance, cell culture clarification, cell separation / product purification, sterilization and others).
• Tabulated profiles of key players based in North America, Europe and Asia-Pacific that are engaged in manufacturing biopharmaceutical filtration systems (shortlisted based on company size and availability of financial information). Each profile includes a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
• An in-depth analysis of recent developments / trends in the biopharmaceutical filtration domain, offering insights on patents that have been filed / granted for biopharmaceutical filters, since 2019, based on relevant parameters, such patent publication year, patent jurisdiction, CPC symbols, emerging focus areas, leading players (in terms of number of patents granted), patent benchmarking (in terms of CPC codes and leading players), patent characteristics and patent age. It also includes an insightful patent valuation analysis and list of leading patents based on number of citations. In addition, it provides information on recent mergers and acquisitions reported in this domain, including details on year, deal amount, regional distribution and key players (in terms of number of deals).
• A detailed analysis of global events that took place in this domain, since 2018 based on several relevant parameters, such as year of event, event platform, type of event, geography, type of filter (based on use) (single-use and reusable filters), type of filter system involved (depth filters, sterilizing grade filters, tangential flow filters, virus filters, virus filters, membrane filters and others), type of process(es) involved (upstream bioprocessing and downstream bioprocessing), most active organizers (in terms of number of events) and application area(s) (type of biologic involved), as well as prominent players.

Frequently Asked Questions

Question 1: What are the different types of filtration systems used in biomanufacturing?

Answer: The various types of filtration systems used in biomanufacturing processes include depth filtration systems, tangential flow filtration systems, virus filtration systems, other membrane filtration systems and chromatography filtration systems.

Question 2: What are the limitations of conventional filter systems?

Answer: The key concerns related to conventional filter systems include limited filtration capacity, need for frequent maintenance, risk of clogging, and limited lifespan. In addition, conventional filters were not very effective in removing certain types of contaminants, such as dissolved minerals, bacteria, viruses or chemicals.

Question 3: How many companies offer filtration systems for biopharmaceutical purposes?

Answer: Presently, more than 80 companies are involved in the development of depth filters, tangential flow filters, virus filters and other membrane filters.

Question 4: How many patents, related to biopharmaceutical filtration, have been filed / granted in the last few years?

Answer: Close to 130 patents have been filed / granted related to biopharmaceutical filtration, in the last few years. It is worth mentioning that most of the patents have been filed by industry players and are focused on virus removal and protein recovery.

Question 5: What are the key trends in the biopharmaceutical filtration market?

Answer: Companies involved in this domain have made significant investments to expand their existing capabilities through the incorporation of advanced methods, technologies and platforms, in order to accommodate the current and anticipated demand for filtration systems. Further, these companies have actively participated in various conferences, meetings, seminars, exhibitions and webinars in order to present their ideas and innovative products / technologies to a wider audience.

Question 6: Which segment, in terms of type of product, is likely to have the largest share in the biopharmaceutical filtration market?

Answer: Presently, membrane filters dominate the biopharmaceutical filtration market. This can be attributed to the fact that these are widely used in biopharmaceutical manufacturing for sterile filtration and virus filtration due to their high efficiency, durability and versatility.

Question 7: How is the biopharmaceutical filtration market likely to evolve in the coming years?

Answer: The biopharmaceutical filtration market is projected to grow at a CAGR of ~10% in the coming years.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. BIOPHARMACEUTICAL FILTRATION: MARKET LANDSCAPE

5. COMPANY COMPETITIVENESS ANALYSIS

6. DEVELOPERS HEADQUARTERED IN NORTH AMERICA: COMPANY PROFILES

7. DEVELOPERS HEADQUARTERED IN EUROPE AND ASIA-PACIFIC: COMPANY PROFILES

8. RECENT DEVELOPMENTS

9. GLOBAL EVENTS ANALYSIS

10. MARKET FORECAST

11. CONCLUSION

12. EXECUTIVE INSIGHTS

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/r/g08ltf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets 
Laura Wood, Senior Manager 
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716

Logo: http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets